Tag: AVH

Avita Medical ASX AVH pediatric scald RECELL system burns

Avita Medical enrols first patients in studies evaluating RECELL system

Regenerative medicine company Avita Medical (ASX: AVH) has commenced what it calls a “pivotal trial” for the treatment of paediatric scald injuries, seeking to demonstrate that its RECELL treatment ca...
AVITA Medical ASX AVH study results RECELL System

AVITA Medical publishes favourable study results for its RECELL System

Regenerative medicine company AVITA Medical (ASX: AVH) has published “favourable” results from an open-label feasibility study of its RECELL Autologous Cell Harvesting Device for the treatment of diab...
AVITA Medical ASX AVH regenerative burn treatment FDA approval

AVITA Medical prepares to launch its regenerative burn treatment in the US

Just over a month since its burns treatment system was approved for FDA’s compassionate use Investigational Device Exemption (IDE) program, regenerative medicine company AVITA Medical (ASX: AVH) has r...
AVITA Medical ASX AVH FDA compassionate use expanded access RECELL device

AVITA Medical receives FDA boost for compassionate use of RECELL device

Medical device maker AVITA Medical (ASX: AVH) has received good news this morning after the US Food and Drug Administration (FDA) said it had approved a program that could use more of its devices. ...
Avita Medical ASX AVH skin regeneration Recell

Avita Medical grafts towards next generation of skin regeneration

Skin regeneration is on course for an overhaul on the back of revelations made by regenerative medicine company Avita Medical (ASX: AVH) with a technology platform able to treat severe burns. RECEL...
Avita Medical ASX AVH recell China skin regeneration

Regenerative commercial potential on the horizon for Avita Medical

A new and potentially cost-saving method of treating second-degree burns developed by Avita Medical (ASX: AVH) is now undergoing a clinical trial in China. Avita hopes to see its RECELL treatment r...
Avita Medical AVH FDA approval ReCell skin regeneration device supplement

Avita Medical gets FDA approval for ReCell skin regeneration device supplement

Avita Medical (ASX: AVH) has gained FDA approval for a new continued access protocol for its ReCell autologous cell harvesting device, which simplifies a previously approved protocol for treating burn...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS